• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

坏死性胰腺炎合并结肠并发症患者临床特征的回顾性队列研究

Clinical characteristics of patients with colon complications after necrotizing pancreatitis: a retrospective cohort study

摘要目的:探讨坏死性胰腺炎患者发生结肠并发症后的临床特征。方法:回顾性分析2014年1月至2021年12月就诊于首都医科大学宣武医院普通外科的403例坏死性胰腺炎患者的临床资料。男性273例,女性130例,年龄(49.4±15.4)岁(范围:18~90岁)。其中胆源性胰腺炎199例,高脂血症性胰腺炎110例,其他原因引起的胰腺炎94例。采用多学科诊疗模式对坏死性胰腺炎患者进行诊治。根据患者有无结肠并发症将患者分为结肠并发症组和无结肠并发症组。结肠并发症组患者采取抗感染、肠外营养支持、保持引流管通畅、末端回肠造瘘等方式进行治疗。采用1∶1倾向性评分匹配(PSM)法对两组患者的临床资料进行匹配。分别通过 t检验、 χ2检验或Fisher确切概率法对组间数据进行分析。 结果:403例坏死性胰腺炎患者中,出现结肠并发症53例,包括结肠漏23例,结肠梗阻15例,结肠出血21例。PSM后,两组各有53例患者。两组患者的基线数据和入院时临床特征具有可比性( P值均>0.05);临床转归方面,与无结肠并发症组相比,结肠并发症组患者接受微创干预的比例[88.7%(47/53)比69.8%(37/53), χ2=5.736, P=0.030]、微创干预次数[ M(IQR)][2(2)次 比1(1)次, Z=4.638, P=0.034]、出现多器官功能衰竭比例[45.3%(24/53)比32.1%(17/53), χ2=4.826, P=0.041]及胰外感染比例[79.2%(42/53)比60.4%(32/53), χ2=4.476, P=0.034]明显增多,需要肠内营养支持时间[8(30)d比2(10)d, Z=-3.048, P=0.002]、肠外营养支持时间[32(37)d比17(19)d, Z=-2.592, P=0.009]、ICU住院时间[24(51)d比18(31)d, Z=-2.268, P=0.002]和总住院时间[43(52)d比30(40)d, Z=-2.589, P=0.013]明显延长。两组患者病死率相近[37.7%(20/53)比34.0%(18/53), χ2=0.164, P=0.840]。 结论:坏死性胰腺炎患者出现结肠并发症可导致坏死性胰腺炎患者住院时间延长和外科干预次数增多,积极的外科干预有助于改善此类患者的预后。

更多

abstractsObjective:To investigate the clinical characteristics of colon complications in patients with necrotizing pancreatitis(NP).Methods:The clinical data of 403 patients with NP admitted to the Department of General Surgery,Xuanwu Hospital, Capital Medical University from January 2014 to December 2021 were retrospectively analyzed. There were 273 males and 130 females,aged (49.4±15.4) years(range: 18 to 90 years). Among them,there were 199 cases of biliary pancreatitis,110 cases of hyperlipidemic pancreatitis,and 94 cases of pancreatitis caused by other causes. A multidisciplinary diagnosis and treatment model was used to diagnose and treat patients. Depending on whether the patients had colon complications,they were divided into colon complications group and noncolon complications group. Patients with colon complications were treated with anti-infection therapy,parental nutritional support,keeping the drainage tube unobstructed,and terminal ileostomy. The clinical results of the two groups were compared and analyzed using a 1∶1 propensity score match(PSM) method. The t test, χ2 test, or rank-sum test was used to analyze data between groups,respectively. Results:The incidence of colon complications was 13.2%(53/403),including 15 cases of colon obstruction,23 cases of colon fistula,and 21 cases of colon hemorrhage. After PSM,the baseline and clinical characteristics at admission of the two groups of patients were comparable (all P>0.05). In terms of clinical outcome,compared to patients with NP without colon complications,the number of patients with colon complications who received minimally invasive intervention(88.7%(47/53) vs. 69.8%(37/53), χ2=5.736, P=0.030),the number of minimally invasive interventions ( M(IQR))(2(2) vs. 1(1), Z=4.638, P=0.034),the number of patients with multiple organ failure(45.3%(24/53) vs. 32.1%(17/53), χ2=4.826, P=0.041),and the number of extrapancreatic infections(79.2%(42/53) vs. 60.4%(32/53), χ2=4.476, P=0.034) increased significantly. The time required for enteral nutrition support(8(30)days vs. 2(10) days, Z=-3.048, P=0.002), parental nutritional support(32(37)days vs. 17(19)days, Z=-2.592, P=0.009),the length of stay in the ICU(24(51)days vs. 18(31)days, Z=-2.268, P=0.002),and the total length of stay (43(52)days vs. 30(40)days, Z=-2.589, P=0.013) were also significantly prolonged. However,mortality rates in the two groups were similar(37.7%(20/53) vs. 34.0%(18/53), χ2=0.164, P=0.840). Conclusions:Colonic complications in NP patients are not rare,which can lead to prolonged hospitalization and increased surgical intervention. Active surgical intervention can help improve the prognosis of these patients.

More
广告
栏目名称 论著
DOI 10.3760/cma.j.cn112139-20230318-00111
发布时间 2025-02-25
基金项目
北京市科学技术委员会首都临床诊疗技术研究及示范应用 首都卫生发展科研专项 首都医科大学临床医学高精尖学科建设项目 Beijing Municipal Science and Technology Commission Clinical Diagnosis and Treatment Technology Research and Demonstration Application Project Capital Medical Development and Research Special Project Construction Project of Clinical Advanced Subjects of Capital Medical University
  • 浏览92
  • 下载4
中华外科杂志

中华外科杂志

2023年61卷7期

567-574页

MEDLINEISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷